IGF2 and Wilms tumor: Bi-allelic Igf2 expression and hypermethylation at the Igf2 DMR2 have been shown in patients with Beckwith–Wiedemann syndrome52, while loss of imprinting of Igf2 DMRs has been shown in patients with Wilms tumour and colorectal cancer55,56.